NDSN — Nordson Corporation

Summary of Nordson Corporation Q1 2026 Earnings Call

1. Key Financial Results and Metrics

• Sales: Record first-quarter sales of $669 million, up 9% year-over-year, with 7% organic growth.
• EBITDA: Increased 8% to $203 million, maintaining EBITDA margins at 30%.
• Net Income: Totaled $133 million or $2.38 per share; adjusted earnings per share reached a record $2.37, a 15% increase from the prior year.
• Free Cash Flow: Generated $123 million, with a conversion rate of 105% of net income.
• Debt: Net debt was approximately $1.9 billion, with a leverage ratio of 2.1x.

2. Strategic Updates and Business Highlights

• Segment Performance:
  • Industrial Precision Solutions (IPS): Sales of $327 million, up 9%, with strong demand in Asia and stabilization in automotive and polymer processing.
  • Medical and Fluid Solutions (MFS): Sales of $193 million, flat year-over-year, impacted by a 1% decline due to weather-related production disruptions.
  • Advanced Technology Solutions (ATS): Sales surged 23% to $149 million, driven by semiconductor applications.
• Cash Deployment: $82 million in share repurchases and $46 million in dividends were paid during the quarter.
• Acquisition Strategy: Active pipeline for acquisitions focused on expanding medical components and test and inspection opportunities.

3. Forward Guidance and Outlook

• Q2 2026 Guidance: Expected sales range of $710 million to $740 million; adjusted earnings forecasted between $2.70 and $2.90 per share.
• Full-Year Guidance: Sales projected between $2.860 billion and $2.980 billion, a 4.5% increase at the midpoint. Adjusted earnings anticipated in the range of $11 to $11.60 per share, a 10% increase at the midpoint.

4. Bad News, Challenges, or Points of Concern

• MFS Segment Slow Start: The medical segment's growth was slower than expected, with weather-related disruptions impacting production and sales.
• Geographic and Product Mix Impact: Lower margins in the IPS segment due to geographic sales concentration in lower-margin regions.
• Market Conditions: While demand is currently strong, there are concerns about potential pullbacks in end-market demand in the second half of the year.

5. Notable Q&A Insights

• Margin Dynamics: Management confirmed that margin pressures were primarily due to geographic mix rather than a fundamental change in margin outlook.
• Medical Segment Outlook: Confidence in mid-single-digit growth for MFS despite a slower start, supported by strong underlying demand and backlog.
• ATS Segment Growth: Strong momentum in the dispense business driven by semiconductor demand; X-ray business showing early signs of recovery.
• M&A Activity: Management remains active in pursuing acquisitions, focusing on strategic growth areas despite elevated multiples in some segments.

This summary encapsulates the key financial metrics, strategic initiatives, forward guidance, and notable concerns discussed during Nordson's Q1 2026 earnings call, providing a comprehensive overview of the company's current performance and outlook.